Successful management of chronic inflammatory demyelinating polyradiculoneuropathy: a rare case report

Deeksha; Jatoth Surendar; Sumanth Marupuru; Atharva Jagawat; Amulya Kalluri; Chatla Sai Sutheertha; E. Rishitha

doi:10.18203/2349-3933.ijam20243067

Authors

Deeksha Government Medical College, Patiala, Punjab, India
Jatoth Surendar Government Medical College Nalgonda, Telangana, India
Sumanth Marupuru Sri Venkateswara Medical College, Alipiri Road Srinivasa Nagar, Tirupati, Andhra Pradesh, India
Atharva Jagawat M.S. Ramaiah Medical College, MS Ramaiah Nagar, Mathikere, Bengaluru, Karnataka, India
Amulya Kalluri NRI Medical College, Mangalagiri Road, Chinakakani, Guntur, Andhra Pradesh, India
Chatla Sai Sutheertha Bicol Christian College of Medicine Legaspi, Philippines
E. Rishitha Kakatiya Medical College, Kaloji Narayan Rao University of Health Sciences, Rangam Peta, Street, Nizampura, Warangal, Telangana, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243067

Keywords:

CIDP, Polyradiculoneuropathy, Demyelinating, Neuropathy, Quadriplegia, Case report

Abstract

Acute immune-mediated demyelinating polyradiculoneuropathy is a rare neuropathic disorder characterized by significant motor involvement. The remitting and relapsing form of this disease is known as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). This case report presents the clinical features, diagnostic process, and successful management of a 37-year-old female patient with CIDP. The patient visited the emergency department with complaints of fever, numbness, and progressive weakness in all limbs. There was a similar previous history of weakness in limbs. The patient was treated with administration of high-dose methylprednisolone which led to resolution of symptoms. This case shows the importance of thorough clinical evaluation and prior history taking.

Metrics

Metrics Loading ...

References

Chronic inflammatory demyelinating polyradiculoneuropathy. Available at: www.hopkinsmedicine.org. Accessed on 17th March 2024.

Chronic inflammatory demyelinating polyradiculoneuropathy: practice essentials, background, pathophysiology. Medicine. 2024. https://emedicine.medscape.com/article.

Chronic inflammatory demyelinating polyneuropathy-NORD (National Organization for Rare Disorders). 2015. Available at: https://rarediseases.org/rare-diseases/chronic. Accessed on 12th March 2024.

Broers Merel C, Bunschoten C, Nieboer D, Lingsma Hester F, Jacobs Bart C. Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiol. 2019;52(3-4):161-72.

Broers MC, Marcel de Wilde, Lingsma HF, van, Verhamme K, Jacobs BC. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands. J Peripheral Nerv Sys. 2022;27(3):182-88.

Gogia B, Rocha Cabrero F, Rai PK. Chronic Inflammatory Demyelinating Polyradiculoneuropathy. PubMed. 2022. Available at: https://www.ncbi.nlm.nih.gov/books.

Mathey EK, Park SB, Hughes RAC. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol, Neurosurg Psych. 2015;86(9):973-85.

Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Natu Rev Neurol. 2011;7(9):507-17.

Quint P, Schroeter CB, Kohle F. Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicentre CIDP cohort. J Neurol. 2024;271(9):5930-43.

Van Doorn IN, Eftimov F, Wieske L, van Schaik IN, Verhamme C. Challenges in the early diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in adults: current perspectives. Therap Clin Risk Manag. 2024;20:111-26.

Van den Bergh PYK, Rajabally YA. Chronic inflammatory demyelinating polyradiculoneuropathy. La Presse Médicale. 2013;42(6):203-15.

Van den Bergh PYK, Doorn PA, Hadden RDM. European academy of neurology/peripheral nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force-second revision. European J Neurol. 2021;28(11):3556-83.

Dziadkowiak E, Waliszewska-Prosół M, Nowakowska-Kotas M, Budrewicz S, Koszewicz Z, Koszewicz M. Pathophysiology of the different clinical phenotypes of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Int J Molec Sci. 2021;23(1):179.

Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. The Lancet Neurol. 2019;18(8):784-94.

Lopate G, Pestronk A, Al-Lozi M. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Archives Neurol. 2005;62(2):249.

Ropper AH. Current treatments for CIDP. Neurol. 2003;60(3):16-22.

Nobile-Orazio E, Cocito D, Jann S. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. The Lancet Neurol. 2012;11(6):493-502.

Brun S, de Sèze J, Muller S. CIDP: current treatments and identification of targets for future specific therapeutic intervention. Immuno. 2022;2(1):118-31.